December 02, 2020 00:49 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Disputes between Trinamool Congress, rebel Suvendu Adhikari 'resolved amicably' | Centre fails to achieve a breakthrough in talks with farmers, next meet on Dec 3 | BSF seizes 25,000 cattles, narcotics worth over Rs 62 crore along Indo-Bangladesh border this year | Centre holds meeting with farmers to find breakthrough in anti-farm laws protest | 'BJP only wants to take credit': Mamata Banerjee hits back at PM Modi over farmers' scheme
Covid-19 vaccine could be ready by December: Serum Institute's Adar Poonawalla Covid-19 Vaccine
Image Credit: Pixabay

Covid-19 vaccine could be ready by December: Serum Institute's Adar Poonawalla

India Blooms News Service | @indiablooms | 29 Oct 2020, 11:08 am

New Delhi/Pune/IBNS: Giving a hope to 1.3 billion people of India, vaccine manufacturer Serum Institute of India (SII)'s chief Adar Poonawalla has said the Oxford University's Covid-19 vaccine can be made available in the country by December 2020.

In an interview with English news channel NDTV, Poonawalla on Wednesday said, "If we don't go for an emergency license, our trials should be over by December and then we can maybe we can launch in India in January subject to the UK trial also being completed which it's on the verge on being completed."

"If the UK in the next two weeks were to unblind their study and share the data and be confident that it's safe, then we can, after two-three weeks, apply to the Indian regulator to look at a possible emergency license if that's what the government of India wants," he added.

The SII chief further said, "That review could take about two-three weeks I imagine and then you can have a vaccine by December but all these would have to happen and I don't want to venture a guess whether that would happen or not happen because it's not my place to do so - that's for the health ministry officials to decide."

The SII is working on multiple Covid-19 vaccines including the one developed by Oxford University, named Covishield in the Asian country.

At a time France and Germany are getting into the anti-Covid-19 lockdown mode again, the Novel Coronavirus tally in India on Thursday went past the 80-lakh mark with the reporting of 49,881 new infections in the last 24 hours.

As per the latest update by India's Health Ministry, the country has reported 517 deaths apparently due to the infection in the last 24 hours.